PROSPECTIVE VALIDATION OF A COST-EFFECTIVE MULTIMODAL CELL-FREE DNA ASSAY FOR EARLY LUNG CANCER DETECTION IN SYMPTOMATIC AND HIGH-RISK COHORTS: AN INTERIM REPORT
Authors:
Van Thien Chi Nguyen, Dac Ho Vo, Trung Hieu Tran, Ngoc Tan Pham, Trong Hieu Nguyen, Thi Van Phan, Thi Ngoc Tien Nguyen, Hoang Anh Cao, Luu Hong Dang Nguyen, Duy Sinh Nguyen, Hung Sang Tang, Hoa Giang, Minh Duy Phan, Hoai-Nghia Nguyen, Le Son Tran1Publisher:International Association for the Study of Lung Cancer (ACLC)
Publication date:20 October 2025This publication supports for the following genetic testing:
CLINICAL UTILITY OF A MULTI-OMIC, cfDNA-BASED ASSAY IN THE EARLY DETECTION OF LUNG CANCER: A CASE SERIES
Authors:
Hong-Dang Luu Nguyen, Phuong-Thuy Le, Minh-Anh Thi Nguyen, Ngoc-Minh Phan, Khanh-Nhu Huynh, Viet-Trinh Ngo, Le-Son Tran, Hung- Sang Tang, Duy-Sinh NguyenPublisher:International Association for the Study of Lung Cancer (ACLC)
Publication date:20 October 2025This publication supports for the following genetic testing:
K-ACCELERATE: A Multicenter Prospective Trial Evaluating the Utility of a ctDNA-Based Assay for Accelerating Multi-Cancer Diagnosis in High-Risk Symptomatic Participants
Authors:
Phuong Thuy Le1, Van Thien Chi Nguyen1, Thi Hue Hanh Nguyen1, Dac Ho Vo1 , Luu Hong Dang Nguyen1, Ngoc Minh Phan1, Viet Trinh Ngo1, Thi Ngoc Tien Nguyen1, Thi Van Phan1, Duy Sinh Nguyen1, Hung Sang Tang1, Hoa Giang1, Minh Duy Phan1, Hoai-Nghia Nguyen1, Le Son Tran1*Publisher:ASCO Annual Meeting
Publication date:01 June 2026This publication supports for the following genetic testing:
Leveraging a hybrid tumor-informed and tumor-agnostic ctDNA assay for optimal ctDNA-MRD detection: A real-world study in Southeast Asia
Authors:
Van-Anh Nguyen Hoang, Tu Nguyen, Le-Tho T Vo, Lan N TuPublisher:ASCO Annual Meeting
Publication date:30 May 2026
A Novel Cell-Free Multi-Omics Approach For Enhancing Multi-Cancer Early Detection
Authors:
Thien-Chi Van Van Nguyen¹˒², Anh-Nhu Nguyen¹˒², Thien-Phuc Hoang Nguyen¹˒², Hanh Thi-Hue Nguyen¹˒², Trung-Hieu Tran¹˒², Tien-Anh Nguyen¹˒², Trang Thi Tran¹˒², Trong Hieu Nguyen¹˒², Hoa Giang¹˒², Minh-Duy Phan¹˒², Hoai-Nghia Nguyen¹˒², Le Son Tran¹˒²Publisher:ASCO Breakthrough
Publication date:09 August 2024This publication supports for the following genetic testing:
Tissue of origin detection for cancer tumor using low-depth cfDNA samples through combination of tumor-specific methylation atlas and genome-wide methylation density in graph convolutional neural networks
Authors:
Nhu Nhat Tan Doan¹#*, Trong Hieu Nguyen¹#*, Trung Hieu Tran¹, Le Anh Khoa Huynh¹˒², Phuoc Loc Doan¹, Thi Hue Hanh Nguyen¹, Van Thien Chi Nguyen¹, Giang Thi Huong Nguyen¹, Hoai-Nghia Nguyen¹, Hoa Giang¹, Le Son Tran¹, Minh Duy Phan¹*Publisher:ASCO Breakthrough
Publication date:09 August 2024
Multimodal analysis of methylation and fragmentomic profiles in plasma cell free DNA for differentiation of benign and malignant breast tumors
Authors:
Thi Tuong Vi Van¹*, Hanh Thi-Hue Nguyen¹, Thien-Chi Van Van Nguyen¹, Dac Ho Vo¹, Trung Hieu Tran², Trong Hieu Nguyen², Nhu Nhat Tan Doan², Le Anh Khoa Huynh², Xuan Vinh Nguyen², Hoa Giang¹˒², Minh-Duy Phan¹˒², Hoai Nghia Nguyen², Le Son Tran¹˒²*Publisher:ASCO Breakthrough
Publication date:09 August 2024This publication supports for the following genetic testing:
FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions’ SPOT-MAS 10 Multi-Cancer Screening Test
Key finding:
SINGAPORE, May 27, 2026 /PRNewswire/ — Gene Solutions, a global biotechnology company advancing accessible genomic solutions for cancer detection and precision oncology, today announced that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to SPOT-MAS 10, its multi-omic blood test designed to detect cancer-associated signals.Authors:
GENE SOLUTIONS SGP PTE. LTD.Publisher:PR Newswire
Publication date:28 May 2026
Gene Solutions Showcases AI-Powered Multi-Omics Liquid Biopsy Innovations at TJCC 2026: Advancing Precision Oncology in Taiwan
Key finding:
TAIPEI, May 22, 2026 /PRNewswire/ — Gene Solutions, an innovative global biotechnology company advancing AI-powered multi-omics solutions for cancer detection and precision oncology, participated in the 30th Taiwan Joint Cancer Conference (TJCC 2026), marking its first major oncology conference presence in Taiwan.Authors:
Gene Solutions Genomics Pte LtdPublisher:PR Newswire
Publication date:22 May 2026
Gene Solutions Announces Strategic Entry into Türkiye with Robust Real-World Evidence at the 2nd International Hereditary Cancers Congress 2026
Authors:
Gene Solutions Genomics Pte LtdPublisher:PR Newswire
Publication date:04 March 2026
Comprehensive validation of a cell-free DNA-based assay for multi-cancer detection: A Vietnamese longitudinal prospective cohort study (K-DETEK)
Authors:
Le Son Tran¹˒², Dang Luu-Hong Nguyen¹˒², Hanh Thi-Hue Nguyen¹˒², et al.Publisher:ASCO Breakthrough
Publication date:09 August 2024This publication supports for the following genetic testing:
triSure NIPT Debuts in Taiwan, Expanding Non-Invasive Prenatal Screening Beyond Aneuploidy
Key finding:
TAIPEI, April 14, 2026 /PRNewswire/ — At the prestigious Taiwan Association of Obstetrics and Gynecology (TAOG) 2026 Annual Meeting—the nation’s largest obstetrics and gynecology society established in 1961— Gene Solutions Taiwan officially introduced triSure, a revolutionary non-invasive prenatal screening technology.Authors:
Gene Solutions Genomics Pte LtdPublisher:PR Newswire
Publication date:14 April 20261
2
3
4
5
…
9
